CHEK2 and acute lymphoblastic leukemia: Due to the finding that OLE upregulated CHK2 in ALL (but not in AML) cell lines, we may speculate that the synergistic/additive effects observed with cytarabine may be related to the concomitant induction of CHK2 in target cells.